Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma
Crossref DOI link: https://doi.org/10.17352/2581-5407.000037
Published Online: 2021-02-13
Published Print: 2021-02-13
Update policy: https://doi.org/10.17352/gjct
Amany R, Keruakous
Silas, Day
Carrie, Yuen
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25